Literature DB >> 21494077

A nationwide seroprevalence of total antibody to hepatitis A virus from 2005 to 2009: age and area-adjusted prevalence rates.

Donghun Lee1, Moran Ki, Anna Lee, Kyoung Ryul Lee, Hee Bong Park, Chang Sub Kim, Bo Young Yoon, Jong Hyun Kim, Young Sok Lee, Sook Hyang Jeong.   

Abstract

BACKGROUND/AIMS: Recent outbreak of hepatitis A in Korea is clearly related to the epidemiological shift of hepatitis A virus (HAV). However, nationwide seroprevalence data have been limited. This study estimated the nationwide, age- and area-adjusted anti-HAV prevalence from 2005 to 2009.
METHODS: Retrospective analysis of the results of total anti-HAV test in 25,140 cases which were requested by 1,699 medical institutions throughout the nation to Seoul Clinical Laboratory from Jan. 1 2005 to Dec. 31 2009 was performed. The estimated seroprevalence was adjusted by area and age of the standard population based on the 2005 Census data from Korea National Statistical Office.
RESULTS: The area-adjusted anti-HAV prevalence in the children younger than 10 years were 33.4% in 2005 and 69.9% in 2009. The most susceptible age groups to HAV infection during the last 5 years were teenagers and the young adults in their age of twenties. The area-adjusted seroprevalence in 2009 were 11.9% in the age group of 20-29 years, 23.4% in the age group of 10-19 years, 48.4% in the age group of 30-39 years. The population in 40-49 years showed geographically different seroprevalence with the lowest rate in Seoul (80%).
CONCLUSIONS: The most susceptible age group to HAV infection is 10-29 years, while the young children less than 10 years showed about 70% seropositivity. The changing seroepidemiology should be monitored continuously for the proper vaccination and patient care.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21494077      PMCID: PMC3304627          DOI: 10.3350/kjhep.2011.17.1.44

Source DB:  PubMed          Journal:  Korean J Hepatol        ISSN: 1738-222X


  15 in total

1.  A simple cost-decision analysis model comparing two strategies for hepatitis A vaccination.

Authors:  S Saab; P Martin; H F Yee
Journal:  Am J Med       Date:  2000-08-15       Impact factor: 4.965

2.  The prevalence of hepatitis A antibodies among Israeli travellers and the economic feasibility of screening before vaccination.

Authors:  E Schwartz; D Raveh
Journal:  Int J Epidemiol       Date:  1998-02       Impact factor: 7.196

3.  Hepatitis A shifting epidemiology in Latin America.

Authors:  J Tanaka
Journal:  Vaccine       Date:  2000-02-18       Impact factor: 3.641

4.  Hepatitis A shifting epidemiology in the Middle East and Africa.

Authors:  H Tufenkeji
Journal:  Vaccine       Date:  2000-02-18       Impact factor: 3.641

5.  The changing epidemiologic pattern of hepatitis A infection in urban Greece.

Authors:  J Kremastinou; V Kalapothaki; D Trichopoulos
Journal:  Am J Epidemiol       Date:  1984-11       Impact factor: 4.897

6.  [The age-specific seroprevalence of hepatitis A virus antibody in Korea].

Authors:  Young Bong Song; Joon Hyoek Lee; Moon Seok Choi; Kwang Cheol Koh; Seung Woon Paik; Byung Chul Yoo; Yoon-Ho Choi; Hee Jung Sohn; Kyung Han Lee; Jong Chul Rhee
Journal:  Korean J Hepatol       Date:  2007-03

7.  [Clinical features of acute hepatitis A in the Western part of Daejeon and Chungnam province: single center experience].

Authors:  Tae Hee Lee; Sun Moon Kim; Gi Se Lee; Euyi Hyeog Im; Kyu Chan Huh; Yong Woo Choi; Young Woo Kang
Journal:  Korean J Gastroenterol       Date:  2006-02

8.  Trends in hepatitis A virus infection with reference to the process of urbanization in the greater Madrid area (Spain).

Authors:  C Amela; I Pachón; R Bueno; C de Miguel; F Martinez-Navarro
Journal:  Eur J Epidemiol       Date:  1995-10       Impact factor: 8.082

9.  Factors influencing the severity of acute viral hepatitis A.

Authors:  Joo Il Kim; Yun Soo Kim; Young Kul Jung; Oh Sang Kwon; Yeon Suk Kim; Yang Suh Ku; Duck Joo Choi; Ju Hyun Kim
Journal:  Korean J Hepatol       Date:  2010-09

10.  Incidence and seroprevalence of hepatitis A virus infections among young Korean soldiers.

Authors:  Cheol-In Kang; Chang-Min Choi; Tae Sung Park; Dong-Jun Lee; Myoung-don Oh; Kang-Won Choe
Journal:  J Korean Med Sci       Date:  2007-06       Impact factor: 2.153

View more
  13 in total

1.  High Prevalence of Symptomatic Hepatitis A Infection in Rural Area of Chaharmahal VA Bakhtiari Province, Iran.

Authors:  Ali Karimi; Seifollah Mortazaei; Mohammad-Taghi Moradi
Journal:  J Clin Diagn Res       Date:  2015-02-01

2.  Clinical factors associated with hepatitis A virus seropositivity in HIV-infected adults living in a country with an epidemiologic shift for hepatitis A virus infection.

Authors:  Ji Hyeon Baek; Chang Oh Kim; Jun Yong Park; Su Jin Jeong; Nam Soo Koo; Hye Won Kim; Sang Hoon Han; Jun Yong Choi; Young Goo Song; June Myung Kim
Journal:  J Korean Med Sci       Date:  2012-07-25       Impact factor: 2.153

3.  Seroprevalence of hepatitis A virus antibody in a population aged 0-30 years in Shanghai, China: implications for hepatitis A immunization.

Authors:  Y Zhu; Z Yuan; Q Zhao; G Chen; B Xu
Journal:  Epidemiol Infect       Date:  2012-06-12       Impact factor: 4.434

4.  Seroepidemiology of hepatitis A in Korea: changes over the past 30 years.

Authors:  Hyunju Lee; Hye Kyung Cho; Jong-Hyun Kim; Kyung-Hyo Kim
Journal:  J Korean Med Sci       Date:  2011-05-18       Impact factor: 2.153

5.  Hepatitis a in developed country, the result should interpret carefully.

Authors:  Seyed-Moayed Alavian
Journal:  Gut Liver       Date:  2011-08-18       Impact factor: 4.519

6.  Factors related to completed status and seropositivity of hepatitis a immunization among children aged 1-3 years and 6-8 years in South Korea.

Authors:  Jee-Young Hong; Mo Ran Ki; Hye-Jung Hwang; Delacroix Sinny; Young-Joon Park; Geun-Ryang Bae; Moo-Sik Lee
Journal:  Osong Public Health Res Perspect       Date:  2013-04

7.  Antibodies against Hepatitis A and Hepatitis B Virus in Intravenous Immunoglobulin Products.

Authors:  Soyoung Lee; Han Wool Kim; Kyung Hyo Kim
Journal:  J Korean Med Sci       Date:  2016-12       Impact factor: 2.153

8.  Nationwide Seropositivity of Hepatitis A in Republic of Korea from 2005 to 2014, before and after the Outbreak Peak in 2009.

Authors:  Kyung-Ah Kim; Anna Lee; Moran Ki; Sook-Hyang Jeong
Journal:  PLoS One       Date:  2017-01-18       Impact factor: 3.240

9.  Risk factors for acute hepatitis A infection in Korea in 2007 and 2009: a case-control study.

Authors:  Joo Youn Seo; Bo Youl Choi; Moran Ki; Hye Lim Jang; Hee Suk Park; Hyun Jin Son; Si Hyun Bae; Jin Han Kang; Dae Won Jun; Jin-Woo Lee; Young Jin Hong; Young Seok Kim; Chang-Hwi Kim; U Im Chang; Jong-Hyun Kim; Hyeon Woong Yang; Hong Soo Kim; Kyeong Bae Park; Jae Seok Hwang; Jeong Heo; In Hee Kim; Jung Soo Kim; Gab Jin Cheon
Journal:  J Korean Med Sci       Date:  2013-06-03       Impact factor: 2.153

10.  Epidemiological investigation of an outbreak of hepatitis A at a residential facility for the disabled, 2011.

Authors:  Hyun-Sul Lim; Kumbal Choi; Saerom Lee
Journal:  J Prev Med Public Health       Date:  2013-03-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.